FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2770690917> ?p ?o ?g. }

• W2770690917 endingPage "651" @default.
• W2770690917 startingPage "646" @default.
• W2770690917 abstract "Triglyceride deposit cardiomyovasculopathy (TGCV) is a rare and newly identified disease among patients requiring cardiac transplantation. TGCV is characterized by cardiomyocyte steatosis and triglyceride (TG)-deposit atherosclerosis, resulting from the abnormal intracellular metabolism of TG. TGCV is classified into primary and idiopathic types. Primary TGCV carries ultra-rare genetic mutations in the adipose triglyceride lipase (ATGL), a rate-liming enzyme that hydrolyzes intracellular TG in adipose and non-adipose tissues. Idiopathic TGCV, first identified among autopsied individuals with diabetes mellitus (DM) with severe heart diseases, shows no ATGL mutations and its causes and underlying mechanisms are still unknown. TGCV is difficult to diagnose in daily clinics, thereby demanding feasible diagnostic procedures. We aimed to develop an assay to measure ATGL activity using peripheral leucocytes. Human his6-ATGL was expressed in COS1 cells, purified to homogeneity, and used to raise a polyclonal antibody neutralizing TG-hydrolyzing activity of ATGL. We developed a selective immunoinactivation assay (SIIA) for the quantitation of ATGL activity in cell lysates of leucocytes by the antibody neutralizing ATGL activities. ATGL activity was measured in 13 idiopathic TGCV patients, with two patients with primary TGCV as the negative control. Healthy (non-DM) and DM controls without heart diseases were also subjected. The developed SIIA assay revealed significant reduction in ATGL activity in leucocytes from patients with idiopathic TGCV who did not carry ATGL mutations as compared with non-DM and DM controls. Thus, ATGL in leucocytes may be an important biomarker for the diagnosis of TGCV and our assay may provide insights into pathophysiology and elucidate the underlying mechanism of TGCV and related disorders." @default.
• W2770690917 created "2017-12-04" @default.
• W2770690917 creator A5009168959 @default.
• W2770690917 creator A5015651263 @default.
• W2770690917 creator A5016587670 @default.
• W2770690917 creator A5021384155 @default.
• W2770690917 creator A5026398846 @default.
• W2770690917 creator A5034587344 @default.
• W2770690917 creator A5034921305 @default.
• W2770690917 creator A5035924543 @default.
• W2770690917 creator A5037417355 @default.
• W2770690917 creator A5045571398 @default.
• W2770690917 creator A5060605626 @default.
• W2770690917 creator A5063048117 @default.
• W2770690917 creator A5067533233 @default.
• W2770690917 creator A5073348950 @default.
• W2770690917 creator A5080530083 @default.
• W2770690917 date "2018-01-01" @default.
• W2770690917 modified "2023-10-02" @default.
• W2770690917 title "Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy" @default.
• W2770690917 cites W1481421501 @default.
• W2770690917 cites W1765894495 @default.
• W2770690917 cites W1978356297 @default.
• W2770690917 cites W1979896763 @default.
• W2770690917 cites W1988179379 @default.
• W2770690917 cites W2029318573 @default.
• W2770690917 cites W2030495906 @default.
• W2770690917 cites W2056019042 @default.
• W2770690917 cites W2063919939 @default.
• W2770690917 cites W2069292073 @default.
• W2770690917 cites W2080092593 @default.
• W2770690917 cites W2090946848 @default.
• W2770690917 cites W2110839026 @default.
• W2770690917 cites W2113050573 @default.
• W2770690917 cites W2125355462 @default.
• W2770690917 cites W2131256997 @default.
• W2770690917 cites W2145546208 @default.
• W2770690917 cites W2156111529 @default.
• W2770690917 cites W2406861466 @default.
• W2770690917 cites W2748810423 @default.
• W2770690917 doi "https://doi.org/10.1016/j.bbrc.2017.11.070" @default.
• W2770690917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29146190" @default.
• W2770690917 hasPublicationYear "2018" @default.
• W2770690917 type Work @default.
• W2770690917 sameAs 2770690917 @default.
• W2770690917 citedByCount "10" @default.
• W2770690917 countsByYear W27706909172018 @default.
• W2770690917 countsByYear W27706909172019 @default.
• W2770690917 countsByYear W27706909172020 @default.
• W2770690917 countsByYear W27706909172021 @default.
• W2770690917 countsByYear W27706909172022 @default.
• W2770690917 countsByYear W27706909172023 @default.
• W2770690917 crossrefType "journal-article" @default.
• W2770690917 hasAuthorship W2770690917A5009168959 @default.
• W2770690917 hasAuthorship W2770690917A5015651263 @default.
• W2770690917 hasAuthorship W2770690917A5016587670 @default.
• W2770690917 hasAuthorship W2770690917A5021384155 @default.
• W2770690917 hasAuthorship W2770690917A5026398846 @default.
• W2770690917 hasAuthorship W2770690917A5034587344 @default.
• W2770690917 hasAuthorship W2770690917A5034921305 @default.
• W2770690917 hasAuthorship W2770690917A5035924543 @default.
• W2770690917 hasAuthorship W2770690917A5037417355 @default.
• W2770690917 hasAuthorship W2770690917A5045571398 @default.
• W2770690917 hasAuthorship W2770690917A5060605626 @default.
• W2770690917 hasAuthorship W2770690917A5063048117 @default.
• W2770690917 hasAuthorship W2770690917A5067533233 @default.
• W2770690917 hasAuthorship W2770690917A5073348950 @default.
• W2770690917 hasAuthorship W2770690917A5080530083 @default.
• W2770690917 hasConcept C126322002 @default.
• W2770690917 hasConcept C134018914 @default.
• W2770690917 hasConcept C140985366 @default.
• W2770690917 hasConcept C171089720 @default.
• W2770690917 hasConcept C181199279 @default.
• W2770690917 hasConcept C185592680 @default.
• W2770690917 hasConcept C2777062983 @default.
• W2770690917 hasConcept C2778163477 @default.
• W2770690917 hasConcept C2778913445 @default.
• W2770690917 hasConcept C2779697368 @default.
• W2770690917 hasConcept C2781197716 @default.
• W2770690917 hasConcept C55493867 @default.
• W2770690917 hasConcept C71924100 @default.
• W2770690917 hasConcept C79879829 @default.
• W2770690917 hasConceptScore W2770690917C126322002 @default.
• W2770690917 hasConceptScore W2770690917C134018914 @default.
• W2770690917 hasConceptScore W2770690917C140985366 @default.
• W2770690917 hasConceptScore W2770690917C171089720 @default.
• W2770690917 hasConceptScore W2770690917C181199279 @default.
• W2770690917 hasConceptScore W2770690917C185592680 @default.
• W2770690917 hasConceptScore W2770690917C2777062983 @default.
• W2770690917 hasConceptScore W2770690917C2778163477 @default.
• W2770690917 hasConceptScore W2770690917C2778913445 @default.
• W2770690917 hasConceptScore W2770690917C2779697368 @default.
• W2770690917 hasConceptScore W2770690917C2781197716 @default.
• W2770690917 hasConceptScore W2770690917C55493867 @default.
• W2770690917 hasConceptScore W2770690917C71924100 @default.
• W2770690917 hasConceptScore W2770690917C79879829 @default.
• W2770690917 hasFunder F4320311405 @default.
• W2770690917 hasIssue "1" @default.

• next